PROBIOTIX HEALTH LS-05 Market Cap ($14.76 Million)
Market Cap & Net Worth: PROBIOTIX HEALTH LS-05 (X90)
PROBIOTIX HEALTH LS-05 market cap. PROBIOTIX HEALTH LS-05 (F:X90) has a market capitalization of $14.76 Million (€12.62 Million) as of November 4, 2026. Listed on the F stock exchange, this Germany-based company holds position #25892 globally and #2217 in its home market, demonstrating a 6.54% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PROBIOTIX HEALTH LS-05's stock price €0.08 by its total outstanding shares 158166666 (158.17 Million). Also see PROBIOTIX HEALTH LS-05 (X90) cash conversion ratio for how efficiently the company converts equity into cash flow.
PROBIOTIX HEALTH LS-05 Market Cap History (2022–2026)
PROBIOTIX HEALTH LS-05 market cap history from 2022 to 2026. Data shows change from $38.83 Million to $15.07 Million (-75.31% CAGR). Check PROBIOTIX HEALTH LS-05 share price for real-time trading data and today's change.
PROBIOTIX HEALTH LS-05 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PROBIOTIX HEALTH LS-05's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore PROBIOTIX HEALTH LS-05 net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
6.09x
PROBIOTIX HEALTH LS-05's market cap is 6.09 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $11.93 Million | $1.67 Million | -$747.00K | 7.13x | N/A |
| 2024 | $11.46 Million | $1.88 Million | -$847.00K | 6.09x | N/A |
Competitor Companies of X90 by Market Capitalization
Companies near PROBIOTIX HEALTH LS-05 in the global market cap rankings as of November 4, 2026. Also see X90 asset base for a full breakdown of the balance sheet.
Key companies related to PROBIOTIX HEALTH LS-05 by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #372 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #411 globally with a market cap of $69.05 Billion USD ( AU$97.59 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #497 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $553.15 |
| #372 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $961.26 |
| #411 | CSL Ltd | AU:CSL | $69.05 Billion | AU$201.16 |
| #497 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $220.83 |
Market Capitalization of PROBIOTIX HEALTH LS-05 (2022–2026)
Market capitalization of PROBIOTIX HEALTH LS-05 from 2022 to today. Between 2022 and today, PROBIOTIX HEALTH LS-05's market cap moved from $38.83 Million to $ 15.07 Million, with a yearly change of -75.31%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €15.07 Million | +29.37% |
| 2025 | €11.65 Million | +1.61% |
| 2024 | €11.46 Million | -3.88% |
| 2023 | €11.93 Million | -69.29% |
| 2022 | €38.83 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of PROBIOTIX HEALTH LS-05 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $14.76 Million USD |
| MoneyControl | $14.76 Million USD |
| MarketWatch | $14.76 Million USD |
| marketcap.company | $14.76 Million USD |
| Reuters | $14.76 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About PROBIOTIX HEALTH LS-05
ProBiotix Health Plc develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally. The company offers YourBiotixMH for menopause health; YourBiotixCH InstaMelt and YourBiotixCH for cholesterol maintenance; and YourBiotixX3 for cholesterol reduction. It also provides YourBiotixBP for blood pressure reduction; and … Read more